AstraZeneca approached drugmaker Gilead about a potential merger. Michael Leuchten Head of Equity Research at UBS joins Yahoo Finance’s On The Move to discuss....
In this article we will check out the progression of hedge fund sentiment towards TG Therapeutics Inc (NASDAQ:TGTX) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]...
The National Bureau of Economic Research said Monday that the COVID-19 crisis has officially launched the U.S. economy into a recession, thus ending the longest economic expansion on record....
Global economies have started reopening, yet the battle against COVID-19 wages on. Researchers and healthcare organizations are racing to develop a vaccine capable of preventing COVID-19 infections, and Wall Street is speculating as to who will emerge victorious.To this end, investor focus has locked in on Inovio Pharmaceuticals (INO). On June 4, Inovio, the International Vaccine Institute (IVI) and Seoul National University (SNU) Hospital announced they would collaborate on the initiation of a Phase 1/2 trial of INO’s COVID-19 DNA vaccine, INO-4800, in South Korea later this month. This will mark the country’s first COVID-19 vaccine clinical study, with it being funded by the Coalition for Epidemic Preparedness Innovations (CEPI) through INO, and supported by both the Korea Center for Disease Control and Prevention of Korea National Institute of Health.Taking a closer look at the study’s design, it is broken down into two stages. These include the evaluation of the candidate’s...
Initial visitors to Sin City following coronavirus shutdowns may feel like they hit a jackpot before they even board a plane. Some Las Vegas casino resorts reopened last week after Nevada lifted coronavirus restrictions that had been in place since late March. Travelers looking to book a room were greeted by an array of deals […]...
